BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8673090)

  • 1. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
    Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
    Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
    Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
    Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutation of BRCA1 in Japanese breast cancer families.
    Inoue R; Fukutomi T; Ushijima T; Matsumoto Y; Sugimura T; Nagao M
    Cancer Res; 1995 Aug; 55(16):3521-4. PubMed ID: 7627958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
    Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson JG; Tavtigian SV; Tulinius H; Ogmundsdottir HM; Eyfjörd JE
    Nat Genet; 1996 May; 13(1):117-9. PubMed ID: 8673089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
    Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ
    Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.
    Katagiri T; Kasumi F; Yoshimoto M; Nomizu T; Asaishi K; Abe R; Tsuchiya A; Sugano M; Takai S; Yoneda M; Fukutomi T; Nanba K; Makita M; Okazaki H; Hirata K; Okazaki M; Furutsuma Y; Morishita Y; Iino Y; Karino T; Ayabe H; Hara S; Kajiwara T; Houga S; Miki Y
    J Hum Genet; 1998; 43(1):42-8. PubMed ID: 9609997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
    Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
    Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL
    Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
    Tavtigian SV; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc JF; Mitchell JT; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder SC; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong AK; Shizuya H; Eyfjord JE; Cannon-Albright L; Tranchant M; Labrie F; Skolnick MH; Weber B; Kamb A; Goldgar DE
    Nat Genet; 1996 Mar; 12(3):333-7. PubMed ID: 8589730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2 germline mutations in Swedish breast cancer families.
    Chen J; Hedman MZ; Arver BW; Sigurdsson S; Eyfjörd JE; Lindblom A
    Eur J Hum Genet; 1998; 6(2):134-9. PubMed ID: 9781057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.